Somatostatin receptors — Drug Target

All drugs that target Somatostatin receptors — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

Somatostatin receptor-targeting peptide · Somatostatin receptor-targeting radioligand therapy · Somatostatin receptor-targeting radioligand

Phase 2 pipeline (1)

• Lu-177 DOTA-TATE · AHS Cancer Control Alberta · Somatostatin receptor-targeting peptide · Oncology
  Lu-177 DOTA-TATE is a radiolabeled peptide that targets somatostatin receptors on neuroendocrine tumors.

Phase 1 pipeline (2)

• 177Lu-RAD204 · Radiopharm Theranostics, Ltd · Somatostatin receptor-targeting radioligand therapy · Oncology
  Alpha-particle emitting radioligand targeting somatostatin receptors
• 177Lu-BetaBart · Radiopharm Theranostics, Ltd · Somatostatin receptor-targeting radioligand · Oncology
  Targeting somatostatin receptors